Dr. John Tyler Nathanson, MD

Dr. Nathanson practices at Trustees of Columbia University in the City of New York in New York, New York.

Dr. Nathanson's NPI, 1891226601, was assigned on March 23, 2017. Dr. Nathanson graduated from Icahn School Of Medicine At Mount Sinai in 2017. Dr. Nathanson holds New York license 321281.

Dr. Nathanson's primary practice is Trustees of Columbia University in the City of New York, at 630 W 168th St, New York, NY 10032 in New York County. The practice phone is (212) 342-5155.

Dr. Nathanson's primary practice is Trustees of Columbia University in the City of New York in New York, New York. Dr. Nathanson is also affiliated with NewYork-Presbyterian/Weill Cornell Medical Center. The medical group on file is ColumbiaDoctors. Dmand AI also links Dr. Nathanson to 1 more group practice or clinic, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Nathanson practices, 2 sites in all. Vendor and product names are available with a free account.

Gastroenterology is Dr. Nathanson's primary specialty in the NPI Registry, under taxonomy code 207RG0100X. Dr. Nathanson is board certified in gastroenterology by the American Board of Internal Medicine. Dmand AI has Dr. Nathanson's licenses on file in 2 states: New York and Pennsylvania.

Dmand AI lists acid reflux and intestinal diverticulosis among the conditions Dr. Nathanson treats.

CMS data shows 569 Medicare services from Dr. Nathanson across 10 procedure codes in 2024, for 308 Medicare patients. Medicare paid $91,497 for them.

CMS counts 308 Medicare patients who saw Dr. Nathanson in 2024. The largest group is 75 to 84, with 137 patients. 75% of them have high cholesterol, and 57% have high blood pressure. 9% are also on Medicaid. Their average risk score is 1.17, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Nathanson's median patient age at 57, with 51% women.

In 2024, Dr. Nathanson wrote 297 Medicare Part D claims for 186 patients. 70% of them were for generic drugs. CMS names the drug for 217 of them, across 4 drugs with 11 or more claims each, at $32,139 in total drug cost. In 2023, CMS named 35 claims across 3 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 100 out of 100 for Dr. Nathanson for performance year 2024, reported through an alternative payment model (APM). Dr. Nathanson accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Nathanson as offering telehealth. CMS counts 66 procedures of colonoscopy by Dr. Nathanson, more than 70% of the clinicians it reports for that procedure.

Dmand AI links 7 papers to Dr. Nathanson, published from 2016 to 2024. The most frequent topics are Referral and Consultation. Dr. Nathanson has published most often in Orthop J Sports Med. Dr. Nathanson's most frequent co-authors are Tanvir F. Choudhri, MD, James Gregory Connolly and Alexa M. Dessy, MD.

CMS Open Payments shows 67 general payments to Dr. Nathanson from 6 drug and device companies from 2021 to 2025. Food and beverage make up the largest share, 100% of the total. Abbvie Inc. paid the most, $745.

Dmand AI lists 1 award for Dr. Nathanson.

Dr. Nathanson graduated from Icahn School Of Medicine At Mount Sinai in 2017. Dr. Nathanson is a member of AOA, ACG, AGA and ASGE.

Dr. Nathanson is in network with 10 carriers, including Aetna, United Healthcare and Cigna. HMO plans come from the most carriers, 5. Check the plan with the practice before a visit.